摘要
下肢深静脉血栓可引起肺栓塞,需重视其危险因素并早期识别.肝素和华法林在特殊情况下可造成血栓.原因不明的血栓病例需警惕肿瘤.华法林半衰期较长,围手术期需用低分子量肝素来过渡.慢性弥散性血管内凝血纤维蛋白原和血小板计数可正常.
出处
《中华全科医师杂志》
2014年第1期7-8,共2页
Chinese Journal of General Practitioners
二级参考文献11
-
1Herrera S, Comerota AJ. Embolization during treatment of deep venous thrombosis : incidence, importance, and prevention. Tech Vasc Interv Radiol, 2011, 14: 58-64.
-
2Raskob EG, Silverstein R, Bratzler WD, et al. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med, 2010, 38(4 Suppl) : 502-509.
-
3Klatsky AL, Armstrong M, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in asian-americans. Am J Cardiol, 2000, 85: 1334-1337.
-
4Galanis T, Kraft WK, Merli GJ. Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Adv Surg,2011,45 :361-390.
-
5Brohi K, Cohen MJ, Ganter MT, eta|. Acute coagulopathy of trauma : hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma, 2008, 64 : 1211-1217.
-
6Cosmi B, Legnani C, Iorio A, et alone and in combination with al. Residual venous obstruction, D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur J Vasc Endovasc Surg, 2010, 39: 356-365.
-
7Parikh S, Motarjeme A, Mcnamara T, et al. Uhrasound-accelerated thrombolysis for the treatment of deep vein thrombosis : initial clinical experience. J Vasc Interv Radiol, 2008, 19: 521- 528.
-
8Btiller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease:the Seventh ACCP Conference on Antithrombotic and Thrombolytie Therapy. Chest, 2004, 126 (3 Suppl) : 401S-428S.
-
9Ll , Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest ,2008,133 (6 Suppl) :454S-545S.
-
10Strijkers RH, Cate-Hoek AJ, Bukkems SF,et al. Management of deep vein thrombosis and prevention of post-thrombotic syndrome. BMJ,2011, 343 :d5916.
共引文献21
-
1陈斌,武理国.下肢软组织损伤并发下肢深静脉血栓9例误诊分析[J].内蒙古中医药,2013,32(11):73-74.
-
2邱天,郭曙光,方伟,苏宏斌,陈匡荣,张铠.下肢深静脉血栓发病的高危因素[J].中华医学杂志,2013,93(29):2279-2282. 被引量:48
-
3方伟,彭明生,邱天,谢映鲜,苏宏斌,张铠,郭曙光.股腘静脉漂浮血栓的诊治初探[J].中国普通外科杂志,2013,22(12):1643-1645. 被引量:11
-
4殷明春.D-二聚体在老年下肢深静脉血栓预测中的临界值探讨[J].中国医药导刊,2014,16(2):313-314. 被引量:7
-
5郭山春,徐传伟,李艳飞.金黄色葡萄球菌脓毒症并下肢深静脉血栓形成1例报告并文献复习[J].中国感染控制杂志,2016,15(2):137-140. 被引量:2
-
6孙振晓,孙宇新,于相芬.抗精神病药物致深部静脉血栓形成及肺栓塞的研究进展[J].中国执业药师,2016,0(9):28-32. 被引量:3
-
7曾维佳,张旭胜.下肢深静脉血栓形成的危险因素及多普勒超声诊断价值分析[J].血栓与止血学,2017,23(2):205-207. 被引量:62
-
8赵艳军,董丽,王盈.专科化护理对颅脑外伤术后昏迷患者下肢深静脉血栓形成的预防[J].中国临床护理,2017,9(6):494-496. 被引量:18
-
9李晓娟,周勤,张红卫,魏楠,代旭,孙娅娜,曾燕荣.围术期干预对妇科恶性肿瘤患者术后下肢深静脉血栓形成的预防效果评价[J].中国病案,2018,19(2):108-112. 被引量:25
-
10叶晓颖.彩色多普勒超声应用于下肢静脉血栓诊断的临床价值[J].深圳中西医结合杂志,2017,27(22):63-65. 被引量:4
同被引文献84
-
1李晓刚,陈德杰.急性下肢动脉栓塞的手术治疗[J].海南医药,2011,22(12):102-103.
-
2Dias-Junior CA, Neto-Neves EM, Montenegro MF, et al. Hemody- namic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute puhnonary embolism [ J ]. Nitric Oxide, 2010,23(4) :284-288.
-
3孙家兴,胡海燕,陈丽丽,等.肝素诱导的肺栓塞患者m小板减少一例并文献复习及指南解读[J/CD].中华临床医师杂志:电子版,2013,7(19):8720.8724.
-
4Heit JA, Lahr BD, Petterson TM, etal. Heparin and warfarin anti- coagulation intensity as predictors of recurrence 'after deep vein thrombosis or pulmonary embolism: a population-based cohort study[ J ]. Blood,2011,118 ( 18 ) :4992-4999.
-
5Hoy $M, Seott I J, Plosker GL. Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis mad pulmonary embolism, and in the prevention of clotting in the extraeorporeal cir- cuit during haemodialysis[ J]. Drags,2010,70(10) :1319-1347.
-
6ZhuXF,ShanZ,MaJY,etal.Investigatingtheroleoftheposttranscriptionalgeneregulatormir-24-3pintheproliferation,migrationandapoptosisofhumanarterialsmoothmusclecellsinarteriosclerosisobliterans[J].CellPhysiolBiochem,2015,36(4):1359-1370.
-
7Satoh-AsaharaN,KotaniK,YamakageH,etal.Cardio-anklevascularindexpredictsfortheincidenceofcardiovasculareventsinobesepatients:amulticenterprospectivecohortstudy-(JapanObesityandMetabolicSyndromeStudy:JOMS)[J].Atherosclerosis,2015,242(2):461-468.
-
8YangXW,YangJ,LiL,etal.Analysisoftherelationshipsbetweenclinicopathologicfactorsandsurvivalingallbladdercancerfollowingsurgicalresection-withcurativeintent[J].PloS-One,2012,7(12):513-515.
-
9CarloP,Nicola-M,PamelaC,etal.Misdiagnosisofsofttissuesarcomasofthelowerlimbassociatedwithdeepvenousthrombosis:reportoftwocasesandreviewoftheliterature[J].BMCMusculoskeletalDisorders,2013,14(2):64-65.
-
10NekiR,FujitaT,KokameK,etal.Geneticanalysisofpatientswithdeepveinthrombosisduringpregnancyandpostpartum[J].IntJHematol,2011,94(13):150-155.
引证文献6
-
1赵玉苗,许爱国.创伤性肺栓塞患者应用华法林治疗前后血流动力学变化及意义[J].中华普外科手术学杂志(电子版),2014,8(4):53-55. 被引量:4
-
2潘易飞,林细吟.认知行为疗法改善下肢动脉硬化闭塞症介入术后病人焦虑及抑郁的效果[J].护理研究(下旬版),2016,30(3):1111-1113. 被引量:21
-
3王栋梅.三七总皂苷干预颅脑外伤术后深静脉血栓形成的效果分析[J].辽宁中医药大学学报,2016,18(7):197-199. 被引量:1
-
4李晓娟,周勤,张红卫,魏楠,代旭,孙娅娜,曾燕荣.围术期干预对妇科恶性肿瘤患者术后下肢深静脉血栓形成的预防效果评价[J].中国病案,2018,19(2):108-112. 被引量:25
-
5罗君玲.改良体位应用对下肢动脉硬化闭塞症患者疼痛程度、血氧分压及满意度的影响[J].中国农村卫生事业管理,2018,38(3):392-394. 被引量:5
-
6黄亚玲,徐子尧,王芳.下肢下垂体位对下肢动脉硬化闭塞症患者影响的meta分析[J].现代临床医学,2022,48(4):293-296. 被引量:1
二级引证文献57
-
1王芳,刘凌云.定量运动联合跨理论模型在下肢动脉硬化闭塞症患者术后的应用观察[J].疾病监测与控制,2020,0(1):77-78. 被引量:1
-
2张友娥,许源源.全子宫切除术后并发下肢静脉血栓形成的预防与护理[J].世界最新医学信息文摘,2020(53):281-281.
-
3谭明秀,胡桂娟,黄光葵,李碧华.预防妇科围手术期患者下肢深静脉血栓的研究进展[J].世界最新医学信息文摘,2020(53):85-87.
-
4涂瑞霞.气压治疗仪预防妇科恶性肿瘤根治术患者术后下肢深静脉血栓形成的效果[J].医疗装备,2019,32(19):179-181. 被引量:7
-
5敬鸿博,何春香,张金龙,谭亚萍.三七通舒胶囊联合阿司匹林治疗老年冠心病的安全性及对凝血酶原时间国际标准化比率、D-二聚体和凝血酶原时间的影响[J].药物评价研究,2018,41(12):2269-2272. 被引量:9
-
6赵玉苗,许爱国.创伤性肺栓塞患者应用华法林治疗前后血流动力学变化及意义[J].中华普外科手术学杂志(电子版),2014,8(4):53-55. 被引量:4
-
7郭梅.创伤性肺栓塞应用华法林治疗前后的血流动力学变化研究[J].中外医疗,2015,34(18):115-116.
-
8黄馨莹.探讨华法林单纯抗凝对2型糖尿病合并肺栓塞患者血流动力学及肺功能的影响[J].中外医学研究,2016,14(31):48-49. 被引量:1
-
9周军传.经肱动脉行介入治疗下肢动脉硬化闭塞症的临床效果观察[J].中国医学创新,2017,14(9):8-11. 被引量:7
-
10何六涛,吴晓虞,余旭舟,陈华春.低分子肝素联合华法林治疗非大面积肺栓塞患者的临床效果分析[J].健康研究,2017,37(3):287-289. 被引量:8
-
1徐奕旻,李佳,吴瑛.2015年欧洲心脏病学会室性心律失常管理和心脏性猝死预防指南精粹[J].中国急救复苏与灾害医学杂志,2016,0(7):715-717. 被引量:2
-
2杨杰,张连胜.肌钙蛋白Ⅰ、肌红蛋白、缺血修饰白蛋白在急性心肌梗死诊治中的应用[J].中国医学创新,2012,9(27):36-37. 被引量:7
-
3赵菊珍,张卫兵,程栋.洛汀新治疗糖尿病肾病40例临床观察[J].洛阳医专学报,2001,19(3):217-218.
-
4汤浩.文迪雅并不增加心脏病发作风险[J].糖尿病之友,2008(8):101-101.
-
5胡大一.ACC第53届学术年会精粹[J].中华医学信息导报,2004,19(7):7-8.
-
6许梅燕,高眉扬,周莉.妊高征与慢性弥散性血管内凝血[J].血栓与止血学,2002,8(2):82-83.
-
7梁海琴,叶凤.糖尿病肾病并低血糖症的诊治体会[J].中国医师杂志,2005,7(11):1520-1520. 被引量:2
-
8张昀,沈敏,庄俊玲,刘暴,曾学军.主动脉瘤相关慢性弥散性血管内凝血的临床特点[J].协和医学杂志,2013,4(1):15-19. 被引量:4
-
9《皮肤科疑难病例精粹》(第二辑)出版[J].临床皮肤科杂志,2009,38(12):777-777.
-
10王克勤.丙型肝炎治疗的曙光——欧洲肝脏研究协会第39届年会会议精粹[J].中华医学信息导报,2004(10):12-13.